行情

ONTX

ONTX

Onconova医疗
NASDAQ

实时行情|Nasdaq Last Sale

3.170
-0.120
-3.65%
休市 16:00 11/26 EST
开盘
3.230
昨收
3.290
最高
3.270
最低
3.130
成交量
16.60万
成交额
--
52周最高
28.95
52周最低
2.890
市值
6,622.31万
市盈率(TTM)
-2.3881
分时
5日
1月
3月
1年
5年
Onconova Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
NEWTOWN, Pa., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that the Company will be p...
GlobeNewswire · 5天前
BRIEF-Onconova Therapeutics Reports Third Quarter 2021 Financial Results And Provides Business Update
reuters.com · 11/11 22:04
Recap: Onconova Therapeutics Q3 Earnings
Onconova Therapeutics (NASDAQ:ONTX) reported its Q3 earnings results on Thursday, November 11, 2021 at 04:00 PM. Here's what investors need to know about the announcement.
Benzinga · 11/11 21:30
Onconova Therapeutics Q3 EPS $(0.22) Beats $(0.33) Estimate
Onconova Therapeutics (NASDAQ:ONTX) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.33) by 33.33 percent. This is a 51.11 percent increase over losses of $(0.45) per share
Benzinga · 11/11 21:04
Onconova Therapeutics 每股收益超过 0.11 美元,收入超过
Onconova Therapeutics (NASDAQ:ONTX): Q3 GAAP EPS of -$0.22 beats by $0.11. Revenue of $0.06M (-14.3% Y/Y) beats by $0.01M. Press Release Cash and cash equivalents as of September 30, 2021,
Seekingalpha · 11/11 21:02
Onconova Therapeutics Earnings Perspective: Return On Capital Employed
Benzinga Pro data, Onconova Therapeutics (NASDAQ:ONTX) reported Q2 sales of $57.00 thousand. Earnings fell to a loss of $4.64 million, resulting in a 13.35% decrease from last quarter.
Benzinga · 11/11 16:56
Notable earnings after Thursday's close
ACHR, AEYE, AGRO, DADAAQN, ARRY, ASTR, AVGR, AVIR, BEEM, BLFS, BLNK, OTCPK:BOWFF, CODX, CPNG, OTCPK:EIFZF, FLO, GAN, GOVX, GP, HYFM, OTCQB:IGXT, INTZ, INUV, JAMF, JOBY, LAZR, LTRX, MAPS, OTC:NWHUF, ONTX,
Seekingalpha · 11/10 22:35
Earnings Outlook For Onconova Therapeutics
Onconova Therapeutics (NASDAQ:ONTX) is set to give its latest quarterly earnings report on Thursday, 2021-11-11. Here's what investors need to know before the announcement. Analysts estimate that Onconova Therapeutics will likely report an Earnings Per Sh...
Benzinga · 11/10 16:01
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解ONTX最新的财务预测,通过ONTX每股收益,每股净资产,每股现金流等数据分析Onconova医疗近期的经营情况,然后做出明智的投资选择。
分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

33.33%强力推荐
33.33%买入
33.33%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测ONTX价格均价为11.50,最高价位12.00,最低价为11.00。
最高12.00
均价11.50
最低11.00
现价3.170
EPS
实际EPS
预期EPS
-0.42-0.32-0.21-0.11
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
机构持股
总机构数: 56
机构持股: 410.41万
持股比例: 19.65%
总股本: 2,089.06万
类型机构数股数
增持
8
22.34万
建仓
18
120.80万
减持
8
18.35万
平仓
6
10.18万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
制药
-0.45%
制药与医学研究
+0.44%
高管信息
Non-Executive Chairman/Independent Director
James Marino
President/Chief Executive Officer/Director
Steven Fruchtman
Chief Financial Officer
Mark Guerin
Senior Vice President/General Counsel
Abraham Oler
Other
Mark Gelder
Independent Director
Jerome Groopman
Independent Director
Viren Mehta
Independent Director
M. Teresa Shoemaker
Independent Director
Jack Stover
暂无数据
ONTX 简况
Onconova Therapeutics, Inc.是一家临床阶段的生物制药公司。该公司主要从事肿瘤疗法的识别与开发业务。该公司致力于发现和开发治疗癌症的小分子候选药物。该公司已创造一种对抗癌细胞的重要特定细胞途径的靶向抗癌剂。该公司拥有三个临床阶段候选产品和多个靶向激酶、细胞代谢或细胞分裂的临床前项目。该公司正在对其主要候选产品rigosertib进行作为静脉注射(IV)或口服的单一用药的测试,口服制剂也正与阿扎胞苷一起进行治疗骨髓增生异常综合征(MDS)与相关癌症的临床试验。该公司的候选产品包括Briciclib和Recilisib。

微牛提供Onconova Therapeutics Inc(NASDAQ-ONTX)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的ONTX股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易ONTX股票基本功能。